PMID- 33058842 OWN - NLM STAT- MEDLINE DCOM- 20210621 LR - 20220531 IS - 1873-3492 (Electronic) IS - 0009-8981 (Linking) VI - 511 DP - 2020 Dec TI - Circulating nicotinamide adenine dinucleotide-ubiquinone oxidoreductase chain 6 is associated with disease activity of anti-neutrophil cytoplasmic antibody-associated vasculitis. PG - 125-131 LID - S0009-8981(20)30491-5 [pii] LID - 10.1016/j.cca.2020.10.009 [doi] AB - BACKGROUND: Increased serum and urinary mitochondrial DNA have been demonstrated in antineutrophil cytoplasmic antibody-associated vasculitis (AAV). Here we investigated the significance of serum nicotinamide adenine dinucleotide-ubiquinone oxidoreductase chain 6 (ND6), which is encoded by mtDNA and can attract neutrophils, in AAV. METHODS: Thirty-seven AAV patients (32 patients with positive myeloperoxidase-ANCA and 5 patients with proteinase 3-ANCA) were enrolled. Relationship between serum ND6 and clinico-laboratory characteristics were analyzed. RESULTS: The ND6 level of patients was higher than normal people (46.56 +/- 23.67 pg/mL vs. 4.95 +/- 2.45 pg/mL, P < 0.001) The ND6 levels of patients who needed hemodialysis at disease onset and who had pulmonary hemorrhage (PH) were higher than that of the corresponding controls (P = 0.004 and 0.044 respectively). The ND6 level negatively correlated with the percentages of normal glomeruli in kidney biopsy. The AUC of ROC curve to diagnose hemodialysis and PH was 0.804 and 0.750 respectively. ND6 level positively correlated with Birmingham Vasculitis Activity Score in active disease, and returned to normal after remission. Patients with higher serum ND6 had higher mortality (P = 0.023). CONCLUSIONS: Serum ND6 increases in active AAV, and its level correlates with the severity of disease. High ND6 level is associated with severe organ injury and predicts poor prognosis of AAV. CI - Copyright (c) 2020 Elsevier B.V. All rights reserved. FAU - Tian, Shun-Li AU - Tian SL AD - Department of Geratology, Tianjin Geriatric Institute, Tianjin Medical University General Hospital, Tianjin 300052, China. Electronic address: tianshunli@tom.com. FAU - Bai, Xue AU - Bai X AD - Department of Nephrology, Tianjin Medical University General Hospital, Tianjin 300052, China. Electronic address: bxue0521@163.com. FAU - Xu, Peng-Cheng AU - Xu PC AD - Department of Nephrology, Tianjin Medical University General Hospital, Tianjin 300052, China. Electronic address: nkxpc@163.com. FAU - Chen, Tong AU - Chen T AD - Department of Hematology, Tianjin Medical University General Hospital, Tianjin 300052, China. Electronic address: chentong2014601004@163.com. FAU - Gao, Shan AU - Gao S AD - Department of Nephrology, Tianjin Medical University General Hospital, Tianjin 300052, China. Electronic address: leeshan1225@sina.com. FAU - Hu, Shui-Yi AU - Hu SY AD - Department of Nephrology, Tianjin Medical University General Hospital, Tianjin 300052, China. Electronic address: hushuiyi33@163.com. FAU - Wei, Li AU - Wei L AD - Department of Nephrology, Tianjin Medical University General Hospital, Tianjin 300052, China. Electronic address: weilee1981@163.com. FAU - Jia, Jun-Ya AU - Jia JY AD - Department of Nephrology, Tianjin Medical University General Hospital, Tianjin 300052, China. Electronic address: jiajunya@126.com. FAU - Yan, Tie-Kun AU - Yan TK AD - Department of Nephrology, Tianjin Medical University General Hospital, Tianjin 300052, China. Electronic address: tiekunyan@163.com. LA - eng PT - Journal Article DEP - 20201012 PL - Netherlands TA - Clin Chim Acta JT - Clinica chimica acta; international journal of clinical chemistry JID - 1302422 RN - 0 (Antibodies, Antineutrophil Cytoplasmic) RN - 0U46U6E8UK (NAD) RN - 1339-63-5 (Ubiquinone) RN - EC 1.- (Oxidoreductases) SB - IM MH - *Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis MH - Antibodies, Antineutrophil Cytoplasmic MH - Humans MH - *NAD MH - Oxidoreductases MH - Ubiquinone OTO - NOTNLM OT - ANCA OT - Formyl peptide OT - Mitochondria OT - ND6 OT - Vasculitis EDAT- 2020/10/16 06:00 MHDA- 2021/06/22 06:00 CRDT- 2020/10/15 20:09 PHST- 2020/04/03 00:00 [received] PHST- 2020/10/07 00:00 [revised] PHST- 2020/10/07 00:00 [accepted] PHST- 2020/10/16 06:00 [pubmed] PHST- 2021/06/22 06:00 [medline] PHST- 2020/10/15 20:09 [entrez] AID - S0009-8981(20)30491-5 [pii] AID - 10.1016/j.cca.2020.10.009 [doi] PST - ppublish SO - Clin Chim Acta. 2020 Dec;511:125-131. doi: 10.1016/j.cca.2020.10.009. Epub 2020 Oct 12.